Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing efavirenz (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely efavirenz 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely efavirenz 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Efavirenz 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely efavirenz 30 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing efavirenz and emtricitabine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Measurement of efavirenz peak concentration using high performance liquid chromatography |
Component |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of efavirenz peak concentration (procedure) |
Component |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing efavirenz in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 50 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely efavirenz 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 50 mg oral capsule |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg oral tablet |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz and emtricitabine and tenofovir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only efavirenz in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz and emtricitabine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 30 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 30 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz- and lamivudine- and tenofovir-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz and lamivudine and tenofovir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz and lamivudine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely efavirenz 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet |
Has precise active ingredient |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Efavirenz (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |